Pennystock - pennystock.com - Global Penny Stocks® Update
General Information:
Latest News:
Track Record Update - 7/3/12 4 Jul 2012 | 05:25 am
Newly added: NAVIDEA BIOPHARMACEUTICALS. Closed position at $4.28 for a 68% GAIN. * View the covered positions for the Newsletter Portfolio. 70% have been for GAINS of 50% or GREATER. The Newslett...
Track Record Update - 6/27/12 28 Jun 2012 | 04:14 am
Newly added: NANOSPHERE, INC. Closed position at $2.53 for a 58% GAIN. LRAD CORP. Closed position at $1.21 for a 68% LOSS. * View the covered positions for the Newsletter Portfolio. 70% have been ...
Track Record Update - 6/26/12 27 Jun 2012 | 05:23 am
Newly added: CELSION CORPORATION. Closed position at $3.24 for a 62% GAIN. ANTHERA PHARMACEUTICALS. Closed position at $3.16 for a 60% GAIN. SATCON TECHNOLOGY. Closed position at 25¢ for a 87% LOSS...
Track Record Update - 6/21/12 22 Jun 2012 | 06:07 am
Newly added: ANTARES PHARMA. Closed position at $3.72 for a 60% GAIN. NETWORK ENGINES. Closed position at $1.45 for a 21% LOSS. (acquired by Unicom Systems). WORLD HEART. Closed position at 29¢ fo...
Newsletter and Current Position Update - 5/16/12 17 May 2012 | 02:45 am
RIGHT NOW! IN THE CURRENT NEWSLETTER! Rated a STRONG BUY from four analysts, this industrial goods manufacturer has been showing steady revenue growth; trading at near its yearly low of $1.00. Four ...
Track Record Update - 5/16/12 17 May 2012 | 02:44 am
Newly added: MEDICINOVA, INC. Closed position at $3.90 for a 58% GAIN. * View the covered positions for the Newsletter Portfolio. 70% have been for GAINS of 50% or GREATER. The Newsletter is publi...
Newsletter and Current Position Update - 4/30/12 1 May 2012 | 03:19 am
RIGHT NOW! IN THE CURRENT NEWSLETTER! Five analysts rate this biotech a STRONG BUY or a BUY as its products are used in such procedures as enhancing fusion in spine surgery; trading at around $2.00. ...
Newsletter and Current Position Update - 4/20/12 17 Apr 2012 | 02:49 am
RIGHT NOW! IN THE CURRENT NEWSLETTER! Five analysts rate this drug maker a STRONG BUY as it develops products for treating central nervous system disorders and pain; trading around $2.00. Five analy...
Newsletter and Current Position Update - 4/2/12 3 Apr 2012 | 03:57 am
RIGHT NOW! IN THE CURRENT NEWSLETTER! Rated a "STRONG BUY" or a 'BUY" by several analysts, this technology company has shown strong revenue growth for the last three years and posted a profit in 2011...
Track Record Update - 3/28/12 29 Mar 2012 | 06:37 am
Newly added: OPNEXT. Closed position at $1.73 for a 19% LOSS. (acquired by Oclaro) * View the covered positions for the Newsletter Portfolio. 70% have been for GAINS of 50% or GREATER. The Newsle...
